The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis-Reference-Cited by-同舟云学术

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Published:2015-05-20 Issue:1 Volume:17 Page:
ISSN:1478-6354
Container-title:Arthritis Research & Therapy
language:en
Short-container-title:Arthritis Res Ther

Author:

Van Roy Maarten,Ververken Cedric,Beirnaert Els,Hoefman Sven,Kolkman Joost,Vierboom Michel,Breedveld Elia,‘t Hart Bert,Poelmans Sofie,Bontinck Lieselot,Hemeryck Alex,Jacobs Sandy,Baumeister Judith,Ulrichts Hans

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s13075-015-0651-0.pdf

Reference48 articles.

1. Colmegna I, Ohata BR, Menard HA. Current understanding of rheumatoid arthritis therapy. Clin Pharmacol Ther. 2012;91:607–20.

2. Silman AJHM. Epidemiology of the rheumatic diseases. 2nd ed. New York: Oxford University Press; 2001.

3. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.

4. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964–75.

5. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2012;51:v3–v11.

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity;Advanced Science;2024-06-18

2. Prospects for the computational humanization of antibodies and nanobodies;Frontiers in Immunology;2024-05-15

3. Functional insights of Tyr37 in framework region 2 directly contributing to the binding affinities and dissociation kinetics in single-domain VHH antibodies;Biochemical and Biophysical Research Communications;2024-05

4. Phage display based biosensing: Recent advances and challenges;TrAC Trends in Analytical Chemistry;2024-04

5. A selection and optimization strategy for single-domain antibodies targeting the PHF6 linear peptide within the tau intrinsically disordered protein;Journal of Biological Chemistry;2024-04